click below
click below
Normal Size Small Size show me how
Pharmacology CH 1,2
medications
| Question | Answer |
|---|---|
| Three types of drug sources | 1. natural plants ex opium purple fox glove 2. chemical synthesis 3 genetic egineering |
| 5 drug classifications | theurapuetic- what it does physiological how it does body system where it works prescription or otc Chemical type barbituates, dermatologic |
| pharmacokinetics | physiologic processing of drugs |
| how does the body process drugs | liver->metabolizes the kidneys excrete |
| pharmacodynamics | physiological response to drug |
| agonist | effect produced |
| antagonist | effect blocked |
| synergists | effect enhanced |
| indicated and contraindicated | indicated means should be given contraindicated means should not be give maybe allergy |
| hypersensitivity | produced from previous taking of the drug |
| idiosyncrasy | unpredicable and is unique to you genetic |
| duration | the time between the drug from time of onset til disappearance |
| onset | from administration til effects seen |
| parenteral | given injected |
| bolus | given all at once throuugh iv |
| reconsitited | mixed |
| orders that can be given in or | standing verbal stat by surgeons preference card |
| prn | given as needed but with a limit |
| 3 characteristics of side effect | unpredicatable expected unavoidable mild |
| FDA | food and drug administration ensures quality of drugs and safety |
| DEA | drug enforcement agency regulates controlled subtances |
| Class 1 | high abuse no medical use marijuana, lsd, and herion |
| Class 2 | high abuse approved meds codeine,morphine, fentanyl, opium, cocaine |
| Class 3 | moderate abuse approved anabolic steriods, limeted codiene preps like tylenol 3 |
| Class 4 | limited abuse barbituates |
| Class 5 | low abuse minimal risks antitussives, antidiarrheals, limited narcotic |
| Osha | protects workers and sharp standards |
| CDC | promotes public safety and health writes sharps protocol for injuries |
| Testing | 2 species both genders before humans |
| 3 clinical testings | 1. clinical pharmacology group of 18-45 dose that is toxix, 2. clinical investigation determines dose few people 3 clinical trials before marketing |
| pharmacogenetics | STUDY OF GENETIC INFLUENCE ON DURG ACTION |
| PHARMACOGENOMICS | STUDY OF GENES THAT DETERMINE THE RESPONSE TO MEDS |